Amadix launches its first product, PreveCol®, for the early detection of colorectal cancer

HM Hospitales and Amadix join forces to promote the early detection of colorectal cancer in asymptomatic people. The test is available at the three sites of HM CIOCC in Madrid, Barcelona and Galicia and in the other centers of HM Hospitales Group, and is aimed at patients between 50 and 75 years, who want to detect early onset of the disease.